GENE SIGNATURES ASSOCIATED WITH REJECTION OR RECURRENCE OF CANCER

• 1. 癌症早诊和转移、复发(HCCR和RhoGDI2)基因检测试剂盒和相关检测方法与应用 [P] . 中国专利： CN101429552A . 2009-05-13
• 2. 癌症早诊和转移、复发(DLK－1和RhoGDI2)基因检测试剂盒和相关检测方法与应用 [P] . 中国专利： CN101429549A . 2009-05-13
• 3. GENE SIGNATURES ASSOCIATED WITH REJECTION OR RECURRENCE OF CANCER [P] . 世界知识产权组织专利： WO2012129488A2 . 2012-09-27

  机译： 与癌症的拒绝或复发相关的基因标志

• 4. Signatures Associated with Rejection or Recurrence of Cancer [P] . 美国专利： US2011034347A1 . 2011-02-10

  机译： 与癌症排斥或复发相关的特征

• 5. SIGNATURES ASSOCIATED WITH REJECTION OR RECURRENCE OF CANCER [P] . 世界知识产权组织专利： WO2009105640A1 . 2009-08-27

  机译： 与癌症被拒绝或复发有关的签名

• 1. Correlation between serum ANXA7, miR-211 levels and RAGE gene polymorphisms and postoperative recurrence of ESD after smoking-induced gastric cancer [J] . Min Zhang, Xiao-Qing Zhou, Bao-Hua Li, 海南医科大学学报（英文版） . 2019,第014期
• 2. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases [J] . Mariana Bustamante Eduardo, Vlad Popovici, Sara Imboden, BMC Cancer . 2019,第1期
• 3. Recurrence‐associated gene signature optimizes recurrence‐free survival prediction of colorectal cancer [J] . Xianglong Tian, Xiaoqiang Zhu, Tingting Yan, Molecular oncology. . 2017,第11期
• 4. A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences [J] . Lorenza Mittempergher, Mahasti Saghatchian, Denise M. Wolf, Molecular oncology. . 2013,第5期
• 5. State-of-the-Art Lecture: A gene expression signature to predict recurrence of Dukes B colon cancer [C] . Y. WANG, T. JATKOE, Y. ZHANG, Falk Symposium . 2006
• 6. Establishing an immune gene signature for stage II cutaneous melanoma at high risk of recurrence. [D] . Sivendran, Shanthi. 2011
• 7. Characterization of molecular scores and gene expression signatures in primary breast cancer local recurrences and brain metastases [O] . Mariana Bustamante Eduardo, Vlad Popovici, Sara Imboden, 2019
• 8. A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores [O] . Takeo Fujii, Hiroko Masuda, Yee Chung Cheng, 2021

• 1. Sum-Based Meta-Analytical Enrichment of Gene Expression Data to Identify Pathway Signatures of Cancers [J] . Kavishwar Wagholikar ,Prasanna Venkatraman ,Sundararajan Vijayraghavan . 癌症治疗（英文） . 2010,第1期
• 2. Do the expressions of gap junction gene connexin messenger RNA in noncancerous liver remnants of patients with hepatocellular carcinoma correlate with postoperative recurrences? [J] . I-ShyanSheen ,Kuo-ShyangJeng ,Shou-ChuanShih . 世界胃肠病学杂志：英文版 . 2005,第2期
• 3. Advances in molecular,genetic and immune signatures of gastric cancer:Are we ready to apply them in our patients' decision making? [J] . Stavros Gkolfinopoulos ,Demetris Papamichael ,Konstantinos Papadimitriou . 世界胃肠肿瘤学杂志：英文版（电子版） . 2018,第7期
• 4. Identification of Small and Discriminative Gene Signatures for Chemosensitivity Prediction in Breast Cancer [J] . Wei Hu . 癌症治疗（英文） . 2011,第2期
• 5. 肿瘤干细胞标志基因CD133的功能位点单核苷酸多态性可预测接受根治性放疗的非小细胞肺癌患者的局部复发和远处转移 [C] . 王启鸣 ,李鹏 ,Hongliang Liu . 第13届全国肺癌学术大会 . 2013
• 6. 早期复发性流产的病因分析及易栓症标志物抗凝血酶-Ⅲ、蛋白C、蛋白S与不明原因复发性流产的相关性研究 [A] . 刘玮 . 2017